Starkage Therapeutics

Lille, France

Starkage Therapeutics is a biotechnology company that aims to delay and improve quality of life of patients with age-related diseases.

$1.3M raised

May 2024

Venture - Series Unknown

Biotechnology Medical

Top Investors

Bpifrance

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Starkage Therapeutics

How much funding has Starkage Therapeutics raised?

Starkage Therapeutics has raised $1.3M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2024.

Who are Starkage Therapeutics's investors?

Starkage Therapeutics's investors include Bpifrance.

Where is Starkage Therapeutics headquartered?

Starkage Therapeutics is headquartered in Lille, France.

What does Starkage Therapeutics do?

Starkage Therapeutics is a biotechnology company that aims to delay and improve quality of life of patients with age-related diseases.

What stage is Starkage Therapeutics at?

Starkage Therapeutics is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 29, 2024.

MLA

"Starkage Therapeutics — Funding & Investors." VCBacked, May 29, 2024, https://www.vcbacked.co/company/starkage-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2024). Starkage Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/starkage-therapeutics

Wikipedia (cite web)

{{cite web |title=Starkage Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/starkage-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 29, 2024.